课题基金 / 基金详情

Determinants of Malaria Disease in Malawi, 5U19AIO89683-02, "Competitive Revision

Determinants of Malaria Disease in Malawi, 5U19AIO89683-02, "Competitive Revision
马拉维疟疾疾病的决定因素,5U19AIO89683-02,“竞争性修订
批准号:
8412261
负责人:
Terrie Ellen Taylor
金额:
$23.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2017-06-30

项目摘要

项目成果

Terrie Ellen Taylor的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Severe malaria (SM) places a disproportionate burden of mortality and death on the children of Sub-Saharan Africa. Death, as a result of SM, is not a direct consequence of parasite load but is associated with excessive inflammatory response(s) in the brain and lungs of SM patients. Parasite-derived activators of the innate immune response, together with inflammatory monocytes, have been implicated in mediating this tissue damage. However, the activation pathways responsible for localized inflammation and compromising the blood brain barrier (BBB) remain to be determined. We propose elucidating the mechanism(s) by: 1. Defining the transcriptional profiles at the sites of damage in tissues from pediatric SM. We propose assembling a transcriptional "road map" of the expression profiles at the sites of tissue damage in the brain and lungs of pediatric SM patients. The expression patterns will be validated by immuno-histological analysis of a broader bank of archived tissues from SM patients. 2. Do hemozoin-loaded peripheral blood monocytes demonstrate the capacity to mediate or exacerbate tissue damage? We will perform transcriptional and functional typing of hemozoin-loaded, peripheral blood monocytes from SM patients to determine whether or not their inflammatory activities correlate with the tissue-damaging pathways elucidated in Specific Aim #1. 3. Can these potentially damaging cells be re-programed by appropriate anti-inflammatory drugs or immune-modulators? We propose in vitro screening of a panel of anti-inflammatory compounds against patients' hemozoin-loaded monocytes to identify compounds capable of defusing the activation cascades that lead to tissue damage and death in SM. The goals of this project are designed to generate a mechanistic understanding of the pathology of disease in the SM patient cohort that is the subject of the parent ICEMR grant.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2023 Malaria GRC & GRS
  • 批准号:
    10609143
  • 项目类别:
  • 资助金额:
    $0.65万
  • 财政年份:
    2023
  • 负责人:
    Terrie Ellen Taylor
  • 依托单位:
Treating Brain Swelling in Pediatric Cerebral Malaria
  • 批准号:
    10539346
  • 项目类别:
  • 资助金额:
    $56.42万
  • 财政年份:
    2016
  • 负责人:
    Terrie Ellen Taylor
  • 依托单位:
Treating Brain Swelling in Pediatric Cerebral Malaria
  • 批准号:
    10307588
  • 项目类别:
  • 资助金额:
    $126.74万
  • 财政年份:
    2016
  • 负责人:
    Terrie Ellen Taylor
  • 依托单位:
Administrative Core
  • 批准号:
    8302216
  • 项目类别:
  • 资助金额:
    $22.91万
  • 财政年份:
    2011
  • 负责人:
    Terrie Ellen Taylor
  • 依托单位:
国内基金
海外基金
GC Malaria - 利用按蚊天然抗疟共生菌阻断疟疾传播
GC Malaria:研发昆虫不育技术用于控制城市疟疾媒介斯氏按蚊
  • 批准号:
    82261128006
  • 项目类别:
    国际(地区)合作与交流项目
  • 资助金额:
    130.00万元
  • 批准年份:
    2022
  • 负责人:
    张东京
  • 依托单位:
户外杀蚊真菌农药研制(GC Malaria)
  • 批准号:
    82261128004
  • 项目类别:
    国际(地区)合作与交流项目
  • 资助金额:
    150.00万元
  • 批准年份:
    2022
  • 负责人:
    彭国雄
  • 依托单位:
GC Malaria:高效实时户外疟疾媒介蚊虫诱捕监测技术和装置的研发
  • 批准号:
    82261128003
  • 项目类别:
    国际(地区)合作与交流项目
  • 资助金额:
    150.00万元
  • 批准年份:
    2022
  • 负责人:
    陈晓光
  • 依托单位: